Does ROPEGINTERFERON ALFA-2B-NJFT Cause Off label use? 210 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 210 reports of Off label use have been filed in association with ROPEGINTERFERON ALFA-2B-NJFT. This represents 15.0% of all adverse event reports for ROPEGINTERFERON ALFA-2B-NJFT.
210
Reports of Off label use with ROPEGINTERFERON ALFA-2B-NJFT
15.0%
of all ROPEGINTERFERON ALFA-2B-NJFT reports
4
Deaths
24
Hospitalizations
How Dangerous Is Off label use From ROPEGINTERFERON ALFA-2B-NJFT?
Of the 210 reports, 4 (1.9%) resulted in death, 24 (11.4%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROPEGINTERFERON ALFA-2B-NJFT. However, 210 reports have been filed with the FAERS database.
What Other Side Effects Does ROPEGINTERFERON ALFA-2B-NJFT Cause?
Fatigue (298)
Pruritus (152)
Headache (135)
Inappropriate schedule of product administration (103)
Product dose omission issue (99)
Influenza like illness (97)
Nausea (91)
Diarrhoea (89)
Arthralgia (88)
Pain (82)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ROPEGINTERFERON ALFA-2B-NJFT Alternatives Have Lower Off label use Risk?
ROPEGINTERFERON ALFA-2B-NJFT vs ROPINIROLE
ROPEGINTERFERON ALFA-2B-NJFT vs ROPIVACAINE
ROPEGINTERFERON ALFA-2B-NJFT vs ROSIGLITAZONE
ROPEGINTERFERON ALFA-2B-NJFT vs ROSUVASTATIN
ROPEGINTERFERON ALFA-2B-NJFT vs ROSUVASTATIN\ROSUVASTATIN